Skip to content
Wenlo
Sign in

News

Market news

Press releases, earnings reports, SEC filings and insider trades from US large-cap companies, and PR Newswire releases from US-listed companies, newest first, with short AI summaries.

  • Press releaseCORCencora Inc.

    CENCORA TO ACQUIRE AMERICAN ONCOLOGY NETWORK TO STRENGTHEN SUPPORT OF COMMUNITY ONCOLOGY

    Cencora Inc. announced it has entered into a definitive agreement to acquire American Oncology Network Inc. at an enterprise value of $2.4 billion. Cencora expects to pay approximately $1.7 billion in cash at closing to increase its ownership in AON to 75%. Additionally, Cencora updated its fiscal year 2026 adjusted diluted earnings per share expectation to be at least $17.90.

    Source: SEC EDGAR

  • Press releaseNEENextEra Energy Inc.

    NextEra Energy reports third-quarter 2026 financial results

    NextEra Energy announced its third-quarter 2026 financial results, reporting net income attributable to NextEra Energy on a GAAP basis of $4.775 billion, or $2.28 per share, and adjusted earnings of $2.592 billion, or $1.24 per share. Florida Power & Light Company reported third-quarter 2026 net income of $1.62 billion, or $0.77 per share. NextEra Energy Resources reported third-quarter GAAP net income attributable to NextEra Energy of $1.491 billion, or $0.71 per share, and adjusted earnings of $1.247 billion, or $0.59 per share.

    Source: SEC EDGAR

  • Press releaseABTAbbott Laboratories

    Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance

    Source: SEC EDGAR

  • Press releaseTDYTeledyne Technologies Incorporated

    TELEDYNE TECHNOLOGIES REPORTS

    Teledyne Technologies Incorporated reported third quarter 2026 net sales of $1,684.9 million, an increase of 9.4% compared with $1,539.5 million for the third quarter of 2025. Net income attributable to Teledyne for the quarter was $272.8 million, or $5.82 per diluted share, compared with $220.7 million, or $4.65 per diluted share, in the prior-year period. The company also announced a raised full year 2026 GAAP diluted earnings per share outlook of $21.71 to $21.87.

    Source: SEC EDGAR

  • Press releaseCMECME Group Inc.

    CME Group Inc. Reports Highest Q3 Revenue on Record for Q3 2026

    CME Group Inc. reported its financial results for the third quarter of 2026, announcing record third-quarter revenue of $1.7 billion. The company posted net income of $1.0 billion, or $2.89 per diluted share, alongside an adjusted net income of $1.1 billion. Additionally, average daily volume reached a third-quarter record of 29.4 million contracts.

    Source: SEC EDGAR

  • Press releaseWABWabtec Corporation

    Wabtec Reports Strong Third Quarter 2026 Results

    Wabtec Corporation announced its third quarter 2026 results, reporting net sales of $3.12 billion, up 8.1% year-over-year. GAAP diluted earnings per share were $2.42, and adjusted diluted earnings per share were $2.83. The company also raised and tightened its full-year 2,026 adjusted earnings per share guidance to a range of $10.85 to $11.05.

    Source: SEC EDGAR

  • Press releaseROIVRoivant Sciences Ltd.

    Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)

    Roivant Sciences Ltd. announced positive results from the Phase 3 CLARITY program evaluating brepocitinib in non-infectious uveitis conducted by its subsidiary Priovant Therapeutics. Brepocitinib met the primary endpoint for both CLARITY-1 and CLARITY-2 studies by demonstrating a statistically significant benefit compared to placebo. Priovant intends to file a supplemental New Drug Application for brepocitinib for the treatment of non-infectious uveitis in the first half of 2027.

    Source: SEC EDGAR

  • Press releasePMPhilip Morris International Inc.

    Philip Morris International Reports 2026 Third-Quarter & First Nine-Months Results

    Philip Morris International Inc. announced its third-quarter and first nine-months results for 2026, reporting a 5.5% increase in net revenues to $11.4 billion. The company posted a reported diluted EPS of $2.12 and an adjusted diluted EPS of $2.36, representing a 5.4% increase. Additionally, management updated its full-year adjusted diluted EPS forecast and raised its regular quarterly dividend by 8.8% to $1.60 per share.

    Source: SEC EDGAR

  • Press releaseMCOMoody's Corporation

    MOODY’S CORPORATION REPORTS RESULTS

    Source: SEC EDGAR

  • Press releaseLHLabcorp Holdings Inc.

    Labcorp Declares Quarterly Dividend

    Labcorp Holdings Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.72 per share of common stock. The dividend is payable on December 11, 2026, to stockholders of record as of November 24, 2026.

    Source: SEC EDGAR

  • Press releaseNTRSNorthern Trust Corporation

    NORTHERN TRUST CORPORATION REPORTS THIRD QUARTER

    Source: SEC EDGAR

  • Press releaseTAT&T Inc.

    AT&T Delivers Strong Third-Quarter 2026 Results with Its Best Consolidated Service Revenue Growth in More Than Four Years

    AT&T Inc. reported third-quarter 2026 results with revenues totaling $32.3 billion, up 5.3% year over year. Diluted EPS from continuing operations was $0.13, and adjusted EPS was $0.65 compared to $0.54 in the year-ago quarter. The company added more than 1 million Advanced Connectivity customers for a second consecutive quarter and updated its 2026 outlook.

    Source: SEC EDGAR

  • 8-KTMOThermo Fisher Scientific Inc.

    Current report

    Thermo Fisher Scientific Inc. reported its financial results for the third quarter ended September 26, 2026. Revenue grew 9% to $12.14 billion, with organic revenue growth of 6%. GAAP diluted EPS increased 9% to $4.64, and adjusted EPS rose 15% to $6.68.

    Source: SEC EDGAR

  • Press releaseELVElevance Health, Inc.

    ELEVANCE HEALTH REPORTS THIRD QUARTER 2026 RESULTS;

    Elevance Health, Inc. reported third quarter 2026 operating revenue of $50.4 billion and diluted earnings per share of $6.27, alongside adjusted diluted EPS of $6.99. The company raised its full-year 2026 diluted EPS guidance to at least $22.00 and adjusted diluted EPS guidance to at least $29.00. Additionally, Elevance Health repurchased 0.8 million shares for $330 million during the quarter.

    Source: SEC EDGAR

  • Press releaseJKSJinko Holdings Limited

    JinkoSolar Announces Results of 2026 Annual General Meeting

    Source: PR NewswireIndustry ECPIndustry ALTIndustry UTIIndustry OILIndustry ENVIndustry GREIndustry CPRIndustry EUTSubject SHM

  • Form 4NTRANatera, Inc.

    Jonathan Sheena (Director) sells NTRA shares

    Jonathan Sheena, Director, CO-FOUNDER of Natera, Inc., sold 1,500 shares of common stock indirectly through trusts in multiple transactions on October 16, 2026, for a total value of $603,710.26 at an average price of $402.47 per share. Following these transactions, 8,250 shares were held indirectly by By Caraluna 2 Trust. The trades were executed pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2026.

    Source: SEC EDGAR

  • Form 4ZSZscaler Inc.

    Robert Schlossman (Chief Legal Officer) reports ZS insider transactions

    Robert Schlossman, Chief Legal Officer of Zscaler Inc., received 14,185 shares as a grant on October 19, 2026. Following this transaction, the insider directly holds 75,710 shares of common stock.

    Source: SEC EDGAR

  • Form 4ZSZscaler Inc.

    Kevin Rubin (Chief Financial Officer) reports ZS insider transactions

    Chief Financial Officer Kevin Rubin received 19,859 shares as a grant on October 19, 2026. After this transaction, he directly holds 62,627 shares of Common Stock.

    Source: SEC EDGAR

  • Form 4ZSZscaler Inc.

    Adam Geller (Chief Product Officer) reports ZS insider transactions

    Chief Product Officer Adam Geller received 19,859 shares as a grant on October 19, 2026. Following this transaction, Adam Geller directly held 58,167 shares of Common Stock.

    Source: SEC EDGAR

  • Form 4UBERUber Technologies Inc.

    Balaji (A) Krishnamurthy (Chief Financial Officer) reports UBER insider transactions

    Balaji (A) Krishnamurthy, Chief Financial Officer of Uber Technologies Inc., acquired 4,392 shares of common stock through RSU vesting and had 2,243 shares withheld for taxes. Following these transactions, the insider directly holds 45,701 shares of common stock.

    Source: SEC EDGAR

  • Form 4UBERUber Technologies Inc.

    Andrew Macdonald (See Remarks) reports UBER insider transactions

    Andrew Macdonald, See Remarks, had RSU vesting transactions acquiring 10,168 shares of Common Stock. In addition, there were tax withholding transactions disposing of 5,684 shares of Common Stock at an average price of $70.35 valued at $399,869.4. After these transactions, the insider directly held 435,287 shares of Common Stock.

    Source: SEC EDGAR

  • Form 4UBERUber Technologies Inc.

    Tony West (See Remarks) reports UBER insider transactions

    Tony West, See Remarks at Uber Technologies Inc., had RSU vesting transactions acquiring 7,195 shares of Common Stock. In addition, 3,569 shares of Common Stock were disposed of for tax withholding at an average price of $70.35, valued at $251,079.15. Following these transactions, the insider directly held 262,124 shares of Common Stock.

    Source: SEC EDGAR

  • Form 4UBERUber Technologies Inc.

    Jill Hazelbaker (See Remarks) reports UBER insider transactions

    See Remarks Jill Hazelbaker acquired 9,160 shares of Common Stock through RSU vesting and disposed of 4,626 shares of Common Stock for tax withholding at an average price of $70.35 per share, valued at $325,439.1. Following these transactions, the insider directly holds 158,593 shares.

    Source: SEC EDGAR

  • Form 4UBERUber Technologies Inc.

    Glen Ceremony (See Remarks) reports UBER insider transactions

    Glen Ceremony, See Remarks at Uber Technologies Inc., had RSU vesting transactions involving 3,611 shares of Common Stock. They also had tax withholding transactions involving 1,793 shares of Common Stock with a total value of $126,137.55 and an average price of $70.35. After these transactions, they directly held 269,955 shares of Common Stock.

    Source: SEC EDGAR

  • Form 4UBERUber Technologies Inc.

    John A Thain (Director) reports UBER insider transactions

    Director John A Thain received 350 shares from RSU vesting on October 16, 2026. Following this transaction, the insider directly held 187,575 shares of Common Stock. No trading plan was noted for this transaction.

    Source: SEC EDGAR

Press releases and filings from SEC EDGAR and PR Newswire. AI summaries can miss details: read the original before you act. Not investment advice.